Sigmoidal kinetic model for two co-operative substrate-binding sites in a cytochrome P450 3A4 active site: an example of the metabolism of diazepam and its derivatives

被引:128
作者
Shou, MG [1 ]
Mei, Q
Ettore, MW
Dai, RK
Baillie, TA
Rushmore, TH
机构
[1] Merck Res Labs, Dept Drug Metab, W Point, PA 19486 USA
[2] NCI, Mol Carcinogenesis Lab, NIH, Bethesda, MD 20892 USA
关键词
cDNA expression; drug interaction; drug metabolism; enzyme kinetics; monoclonal antibody;
D O I
10.1042/0264-6021:3400845
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Cytochrome P450 3A4 (CYP3A4) plays a prominent role in the metabolism of a vast array of drugs and xenobiotics and exhibits broad substrate specificities. Most cytochrome P450-mediated reactions follow simple Michaelis-Menten kinetics. These parameters are widely accepted to predict pharmacokinetic and pharmacodynamic consequences in vivo caused by exposure to one or multiple drugs. However, CYP3A4 in many cases exhibits allosteric (sigmoidal) characteristics that make the Michaelis constants difficult to estimate. In the present study, diazepam, temazepam and nordiazepam were employed as substrates of CYP3A4 to propose a kinetic model. The model hypothesized that CYP3A4 contains two substrate-binding sites in a single active site that are both distinct and co-operative, and the resulting velocity equation had a good fit with the sigmoidal kinetic observations. Therefore, four pairs of the kinetic estimates (K-S1, K-alpha, K-S2, k(beta), K-S3, k(delta), K-S4, and k(gamma)) were resolved to interpret the features of binding affinity and catalytic ability of CYP3A4. Dissociation constants K-S1 and K-S2 for two single-substrate-bound enzyme molecules (SE and ES) were 3-50-fold greater than K-S3 and K-S4 for a two-substrate-bound enzyme (SES), while respective rate constants k(delta) and k(gamma) were 3-218-fold greater than k(alpha) and k(beta), implying that access and binding of the first molecule to either site in an active pocket of CYP3A4 can enhance the binding affinity and reaction rate of the vacant site for the second substrate. Thus our results provide some new insights into the co-operative binding of two substrates in the inner portions of an allosteric CYP3A4 active site.
引用
收藏
页码:845 / 853
页数:9
相关论文
共 34 条
[1]   DIAZEPAM METABOLISM BY HUMAN LIVER-MICROSOMES IS MEDIATED BY BOTH S-MEPHENYTOIN HYDROXYLASE AND CYP3A ISOFORMS [J].
ANDERSSON, T ;
MINERS, JO ;
VERONESE, ME ;
BIRKETT, DJ .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1994, 38 (02) :131-137
[2]  
ATKINSON DE, 1965, J BIOL CHEM, V240, P2682
[3]   FACTORS INFLUENCING THE METABOLISM OF DIAZEPAM [J].
BERTILSSON, L ;
BAILLIE, TA ;
REVIRIEGO, J .
PHARMACOLOGY & THERAPEUTICS, 1990, 45 (01) :85-91
[4]   Inhibitory and non-inhibitory monoclonal antibodies to human cytochrome P450 3A3/4 [J].
Gelboin, HV ;
Krausz, KW ;
Goldfarb, I ;
Buters, JTM ;
Yang, SK ;
Gonzalez, FJ ;
Korzekwa, KR ;
Shou, MG .
BIOCHEMICAL PHARMACOLOGY, 1995, 50 (11) :1841-1850
[5]   HUMAN P450PCN1 - SEQUENCE, CHROMOSOME LOCALIZATION, AND DIRECT EVIDENCE THROUGH CDNA EXPRESSION THAT P450PCN1 IS NIFEDIPINE OXIDASE [J].
GONZALEZ, FJ ;
SCHMID, BJ ;
UMENO, M ;
MCBRIDE, OW ;
HARDWICK, JP ;
MEYER, UA ;
GELBOIN, HV ;
IDLE, JR .
DNA-A JOURNAL OF MOLECULAR & CELLULAR BIOLOGY, 1988, 7 (02) :79-86
[6]   ROLE OF HUMAN CYTOCHROMES P450 IN THE METABOLIC-ACTIVATION OF CHEMICAL CARCINOGENS AND TOXINS [J].
GONZALEZ, FJ ;
GELBOIN, HV .
DRUG METABOLISM REVIEWS, 1994, 26 (1-2) :165-183
[7]  
GONZALEZ FJ, 1989, PHARMACOL REV, V40, P243
[8]  
GUENGERICH FJ, 1988, ASSESSMENT USE SINGL, P161
[9]  
GUENGERICH FP, 1990, CRIT REV BIOCHEM MOL, V25, P97
[10]   Analysis of human cytochrome P450 3A4 cooperativity: Construction and characterization of a site-directed mutant that displays hyperbolic steroid hydroxylation kinetics [J].
Harlow, GR ;
Halpert, JR .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (12) :6636-6641